Delivery Order SPE2DB20D9331-SPE2DB25FL0P1

Award Date 1/23/25
Potential Completion Date 2/13/25
Potential Value $3.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. government agency, the Defense Logistics Agency (DLA), awarded a $1,547.40 firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract has a period of performance through September 25, 2024, and is for the provision of the pharmaceutical product Xolair 150 mg/mL syringe. This delivery order is placed under DMS Pharmaceutical Group's larger $499,999,999 indefinite delivery...
This federal contract award is a delivery order for $11,605.50 issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of Xolair 150 mg/ml syringes, a specialized pharmaceutical product, with a completion date of September 7, 2023. DMS Pharmaceutical Group Inc. holds a significant $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $37,137.60 contract is for the delivery of Xolair 150 mg/mL syringes to support the recurring medical supply needs of military health facilities. This award is part of DMS Pharmaceutical Group's larger indefinite delivery contract (IDC) with the DLA, valued at up to $499,999,999,...
This is a federal contract award from the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a delivery order valued at $98,132.40 for the pharmaceutical product Xolair 150 mg/mL syringe. The contract is a firm fixed-price award with an ultimate completion date of August 22, 2022. DMS Pharmaceutical Group Inc. holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with...
The U.S. Defense Logistics Agency (DLA) awarded a $3,094.80 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business located in Park Ridge, Illinois. The order, which is not associated with a specific set-aside designation, is for the pharmaceutical product Xolair 150 mg/mL syringe. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the agency to issue firm fixed-price...
The Defense Logistics Agency (DLA) awarded a delivery order contract worth $30,948.00 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the provision of Xolair 150 mg/ml syringes, a specialty pharmaceutical product, with a period of performance through June 11, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS Pharmaceutical Group holds with the DLA, which allows...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $37,137.60 firm fixed-price delivery order is for the supply of Xolair 150 mg/mL syringes. The contract has an ultimate completion date of December 26, 2024. DMS Pharmaceutical Group Inc. holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $3,094.80 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the supply of Xolair 150 mg/ml syringes, with a period of performance through September 25, 2024. DMS Pharmaceutical Group holds a larger indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to $499,999,999, which runs through December 31, 2025....
This federal contract award from the Defense Logistics Agency (DLA) was issued to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $5,415.90 firm fixed-price delivery order is for the supply of Xolair 150 mg/mL syringes. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the agency to issue delivery orders for a wide range of pharmaceutical...
This federal contract award was made by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The award is a delivery order under a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that runs through December 31, 2025. This IDC allows the DLA to place firm fixed-price delivery orders with DMS Pharmaceutical Group for a comprehensive range of pharmaceutical items to support...
  • SPE2DB20D9331
    Indefinite Delivery Contract
  • SPE2DB20D9331-SPE2DB25FL0P1
    Delivery Order

This federal contract award, valued at $3,094.80, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a delivery order for the pharmaceutical product Xolair 150 mg/ml syringe. It is a firm fixed-price contract with a period of performance through February 13, 2025.

DMS Pharmaceutical Group Inc. holds a significant $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the agency to issue delivery orders for a comprehensive range of pharmaceutical products to support the medical supply needs of military health facilities worldwide. This specific delivery order is one of many awarded to DMS Pharmaceutical Group Inc. to provide branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables to the Department of Defense.

Generated 4/24/25, 9:46 AM